Primary Record
Acalabrutinib
- In stock
- 4,905 g
- Purity
- 99.8 %
- CAS
- 1420477-60-6
Compound Identifiers & Properties
- CAS
- 1420477-60-6
- PubChem CID
- 71226662
- SMILES
- CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5
- Canonical SMILES
- CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12
Names & Synonyms
- Acalabrutinib
- Calquence
- 1420477-60-6
- acalabrutinibum
- ACP-196
- Acalabrutinib [INN]
- Calquence (TN)
- Acalabrutinib (ACP-196)
- Acalabrutinib(ACP196)
- Acalabrutinib enantiomer
- RefChem:57414
- Acalabrutinib (Standard)
- Acalabrutinib [USAN:INN]
- ACP-196;Acalabrutinib
- I42748ELQW
- UNII-I42748ELQW
- ACALABRUTINIB [MI]
- MFCD29472294
- ACALABRUTINIB [JAN]
- ACALABRUTINIB [USAN]
- CHEBI:167707
- ACALABRUTINIB [WHO-DD]
- ACP196
- DTXSID401026209
- GTPL8912
- orb1303984
- Acalabrutinib (JAN/USAN/INN)
- CHEMBL3707348
- SCHEMBL14637368
- SCHEMBL29376537
- ACP 196
- AMY5290
- EX-A881
- L01XE51
- WDENQIQQYWYTPO-IBGZPJMESA-N
- BDBM737806
- C26H23N7O2
- DTXCID401510462
- GLXC-90498
- ACALABRUTINIB [ORANGE BOOK]
- KS-000006AD
- KS-000006AT
- BDBM50175583
- EBC-17121
- HY-17600R
- NSC791164
- NSC800976
- s8116
- AKOS030526094
- ZINC208774715
- ACN-051536
- CCG-269407
- CS-5356
- DB11703
- DS-3326
- NSC-791164
- NSC-800976
- US12291534, Compound Acalabrutinib
- NCGC00479074-01
- BP-43623
- CID:71226662
- FA138815
- HY-17600
- SC-41557
- SY099670
- Bruton Tyrosine Kinase Inhibitor ACP-196
- SID:406166231
- Example 6 [US20140155385 A1]
- FT-0700196
- NS00073620
- J3.695.616J
- D10893
- (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide
- Benzamide, 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-
- EN300-7369651
- A857446
- BRD-K64034691-001-01-9
- Q23668732
- C000604908
- Z2238902271
- B0084-470855
- 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-(2-pyridyl)benzamide
- 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide
- Benzamide, 4-(8-amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinyl-
- (S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- 4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide
- 1952316-43-6
- 4-(8-Amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinylbenzamide
- 4-(8-amino-3-((2S)-1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo(1,5-a)pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- 4-(8-amino-3-((2S)-1-but-2-ynoylpyrrolidin-2-yl)imidazo(1,5-a)pyrazin-1-yl)-N-pyridin-2-ylbenzamide
- 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-Benzamide
- 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide; ACP 196
- 4-{8-Amino-3-[(2S)-1-(2-butynoyl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl}-N-(2-pyridinyl)benzamide
- 814-272-0
- N-(2-Pyridinyl)-4-[8-amino-3-[(2S)-1-(2-butynoyl)pyrrolidine-2-yl]imidazo[1,5-a]pyrazine-1-yl]benzamide